Afterpay reckons this 1 number shows its 'moat'

One metric shows stark difference between the Australian company and both its old school and buy now, pay later rivals.

Red paper plane zooming ahead of an army of white paper plane competition

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Afterpay Ltd (ASX: APT) showed off a statistic on Thursday it claims sets it apart from its rivals.

The buy now, pay later (BNPL) provider displayed the evidence in its results presentation, where it announced a 112% boost in sales to hit $11.1 billion.

The table shows Afterpay only receives 14% of its revenue from customer fees, compared to more than 60% for its BNPL rivals and 80% for credit cards.

Provider Income from customer fees Income from merchant fees
Afterpay 14% 86%
BNPL US competitor 1 67% 33%
BNPL US competitor 2  67% 33%
BNPL Australia competitor 63% 37%
Credit cards 80% 20%
Source: Afterpay. Table created by author.

Afterpay chief executive Anthony Eisen said this differentiates the service from both old world and new world competitors.

"We don't need customers to lose for us to win," he said.

"We don't rely on customers to go into revolving debt to make money."

Eisen said this has been the philosophy throughout the company's 5-year existence.

"We don't charge interest. We cap late fees. We still, as we have from day one, suspend accounts when a single payment is missed. The idea is you use Afterpay to own something – you don't use it to rent something."

The average order is worth $153, which Afterpay considers a low amount, and the average outstanding balance is just $190.

"We only let customers spend more if they demonstrate good behaviour."

The moat keeps rivals and regulators away

Of course, it is in Afterpay's interests to continue to push the line that it is not a credit provider.

The company is still co-operating with the Australian Securities and Investments Commission and AUSTRAC in their enquiries into the BNPL sector.

Its business model would be substantially impacted if authorities decided Afterpay and its rivals required the same level of regulation as traditional credit.

Eisen said its BNPL competitors largely had the same motivations as old credit card providers.

"When you look at traditional credit models, they make more money when consumers spend beyond their means or when they miss payments."

Afterpay claims that on home loan applications, spending on its platform is counted as an expense. This is compared to a credit card, which results in a loss in borrowing power for the applicant.

Afterpay's share price dipped Thursday morning after the release of its financial results. It has since recovered to be 0.85% up at 3.38 pm AEST, to trade at $91.49.

Motley Fool contributor Tony Yoo owns shares of AFTERPAY T FPO. The Motley Fool Australia owns shares of AFTERPAY T FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A man in a suit smiles at the yellow piggy bank he holds in his hand.
Share Market News

Forget Westpac shares, these ASX ETFs could be better buys

Here's why these funds could be quality picks for investors looking for alternatives to the banks.

Read more »

A male investor wearing a white shirt and blue suit jacket sits at his desk looking at his laptop with his hands to his chin, waiting in anticipation.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another tough day for investors.

Read more »

Rising real estate share price.
REITs

Macquarie names its top 4 ASX REITs to buy today

Macquarie expects these four dividend paying ASX REITs will all surge higher in 2026.

Read more »

A doctor or medical expert in COVID protection adjusts her glasses, indicating growth or strong share price movement in ASX medical, biotech and health companies
Opinions

Forget CSL shares, I'd buy this booming biotech stock instead

This ASX biotech stock has caught my eye this year.

Read more »

Man with virtual white circles on his eye and AI written on top, symbolising artificial intelligence.
Broker Notes

Why this ASX AI stock could return 40% in 2026

Let's see which stock Bell Potter is tipping to rise strongly.

Read more »

A medical researcher rests his forehead on his fist with a dejected look on his face while sitting behind a scientific microscope with another researcher's hand on his shoulder as if giving comfort.
Healthcare Shares

Telix Pharmaceuticals shares crash 58% from their peak: Buying opportunity or time to sell up?

The biopharmaceutical company's shares are tipped to soar next year.

Read more »

Red buy button on an apple keyboard with a finger on it representing asx tech shares to buy today
Share Market News

Analysts name 2 top ASX 200 shares to buy today

Leading investment experts name two quality ASX 200 shares to buy now.

Read more »

Woman leaping in the air and standing out from her friends who are watching.
Broker Notes

This ASX 200 gold stock has surged 77% in 2025. Here's why Macquarie expects it to leap another 23%

Macquarie forecasts 23% upside for this surging ASX gold stock, and that doesn’t include the dividends!

Read more »